Subgroup analyses of etanercept in pediatric patients with psoriasis - 24/04/13
Doi : 10.1016/j.jaad.2009.11.001
Amy S. Paller, MD a, ⁎ 
, Lawrence F. Eichenfield, MD b, Richard G. Langley, MD c, Craig L. Leonardi, MD d, Elaine C. Siegfried, MD e, Kara Creamer, MS f, Gregory Kricorian, MD f
, Lawrence F. Eichenfield, MD b, Richard G. Langley, MD c, Craig L. Leonardi, MD d, Elaine C. Siegfried, MD e, Kara Creamer, MS f, Gregory Kricorian, MD f a Children’s Memorial Hospital and Northwestern University Medical School, Chicago, Illinois
b Rady Children’s Hospital and the University of California San Diego, San Diego, California
c Dalhousie Medical School, Halifax, Nova Scotia, Canada
d Saint Louis University School of Medicine, Saint Louis, Missouri
e Cardinal Glennon Children’s Hospital and Saint Louis University, Saint Louis, Missouri
f Amgen, Thousand Oaks, California
Correspondence to: Amy S. Paller, MD, Department of Dermatology, Children’s Memorial Hospital and Northwestern University Medical School, 676 N St Clair St, Ste 1600, Chicago, IL 60611-2941| Supported by Immunex, a wholly owned subsidiary of Amgen, and by Wyeth Pharmaceuticals. Financial support for the preparation of the manuscript was provided by Amgen. |
|
| Dr Paller is an investigator for Amgen and serves as a consultant for and receives honoraria from Centocor and Abbott Laboratories. Dr Eichenfield is an investigator and past consultant for Amgen and is a consultant and receives an honorarium from Centocor. Dr Langley is on the scientific advisory boards of Amgen, Wyeth, Centocor, Serono, and Abbott Laboratories; serves on the speakers’ bureaus for Amgen, Wyeth, Abbott Laboratories, Serono, and Biogen Idec; receives research support from Amgen, Wyeth, Centocor, Serono, and Abbott Laboratories; and receives other grant support from Abbott Laboratories, Amgen, Biogen Idec, Boehringer Ingelheim, Centocor, Celgene, Isotechnika, and Serono. Dr Leonardi is a consultant for Amgen, Abbott, Centocor, and Genentech; serves as an investigator for Amgen, Abbott, Allergan, Altana, Alza, Astellas, Celgene, Centocor, Genentech, Bristol Myers, Eli Lilly, Galderma, Genyme, Pfizer, Incyte, CombinatoRx, 3M Pharmaceuticals, Perrigo Israel Pharmaceutical, ScheringPlough, RTL, Novartis, Vitac, and Wyeth; and serves on the speakers’ bureau for Amgen, Abbott, Centocor, Genentech, and Warner Chilcott. Dr Siegfried is a consultant and investigator for Amgen, an investigator for Leo, and a consultant for Abbott Laboratories. Ms Creamer and Dr Kricorian are Amgen employees and receive stock or stock options from Amgen. |
© 2010
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 63 - N° 2
P. e38-e41 - août 2010 Retour au numéro
Article précédent
- Indications of therapy in subcutaneous implantation of mercury
- Sergio Vano-Galvan
- Acute patchy exanthematous pustulosis caused by sulfamethoxazole-trimethoprim
- Ivy Lee, Maria Turner, Chyi-Chia Richard Lee
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?